PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma

BACKGROUND: As hepatocellular carcinoma (HCC) having the second-highest mortality rate globally, the early diagnosis and prognosis of HCC have always been the focus of various studies. Although PSME4 has been reported to be closely related to several malignancies, its role in HCC remains unclear. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Sijia, Huang, Hua, Huang, Wei, Ji, Ran, Chen, Jing, Wu, Shuzhen, Wang, Liyang, Huang, Tianxin, Sheng, Yu, Yan, Haiou, Lu, Cuihua, Ma, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801729/
https://www.ncbi.nlm.nih.gov/pubmed/35115815
http://dx.doi.org/10.2147/IJGM.S344360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801729/
https://www.ncbi.nlm.nih.gov/pubmed/35115815
http://dx.doi.org/10.2147/IJGM.S344360

Ejemplares similares